Mar 4, 2026 07:05AM
Feb 20, 2026 07:03AM
Dec 9, 2025 07:00AM
Dec 2, 2025 07:01AM
Nov 26, 2025 05:59AM
Nov 19, 2025 07:03AM
Nov 18, 2025 08:30AM Fennec Pharmaceuticals closes $5 million private share offering in Canada
Nov 18, 2025 08:30AM
Nov 17, 2025 04:15PM
Nov 17, 2025 04:15PM
Nov 13, 2025 11:12PM
Nov 13, 2025 11:11PM
Nov 13, 2025 11:07PM
Nov 13, 2025 11:07PM Fennec Pharmaceuticals Announces Pricing of Offering of Common Shares
Nov 13, 2025 04:08PM
Nov 13, 2025 04:08PM
Nov 13, 2025 04:01PM
Aug 14, 2025 06:08AM
Aug 11, 2025 07:12AM
May 13, 2025 06:03AM
May 8, 2025 04:17PM Fennec Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025
Mar 10, 2025 06:03AM
Mar 6, 2025 04:22PM
Feb 7, 2025 07:00AM
Dec 20, 2024 06:16AM
Dec 19, 2024 06:13AM
Dec 12, 2024 07:01AM
Nov 13, 2024 06:27AM Fennec Pharmaceuticals to Participate in Upcoming Investor Conference
Nov 7, 2024 06:13AM
Oct 31, 2024 06:23AM
Oct 28, 2024 06:23AM
Sep 5, 2024 06:56AM
Aug 13, 2024 06:05AM
Aug 6, 2024 04:31PM
Aug 5, 2024 06:27AM Jeffrey S. Hackman Appointed as CEO and Director at Fennec Pharmaceuticals (FENC)
Aug 5, 2024 06:26AM
Jul 1, 2024 06:00AM
May 14, 2024 06:03AM
May 7, 2024 06:15PM
Mar 21, 2024 06:00AM
Mar 19, 2024 06:01AM
Mar 17, 2024 09:02PM Fennec Pharmaceuticals (FENC) and Norgine Enter into Exclusive Licensing Agreement
Mar 17, 2024 09:00PM
Feb 29, 2024 07:04AM
Feb 1, 2024 05:55AM
Dec 5, 2023 05:55AM
Nov 9, 2023 04:50PM
Nov 6, 2023 05:59AM
Oct 30, 2023 06:45AM Fennec Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 6, 2023
Sep 7, 2023 05:59AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All